î
îŒ
ãã°ã€ã³
î
Regencell Bioscience Holdings Ltd
RGC25.670USD
+0.270+1.06%
çµå€Â 03/27, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
324.52Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± Regencell Bioscience Holdings Ltd äŒæ¥å
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Regencell Bioscience Holdings Ltdã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãRGC
äŒç€ŸåRegencell Bioscience Holdings Ltd
äžå Žæ¥Jul 16, 2021
æé«çµå¶è²¬ä»»è
ãCEOã- -
åŸæ¥å¡æ°12
蚌åžçš®é¡Ordinary Share
決ç®ææ«Jul 16
æ¬ç€Ÿæåšå°11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
éœåž
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœHong Kong
éµäŸ¿çªå·- -
é»è©±çªå·85221550823
ãŠã§ããµã€ãhttps://www.regencellbioscience.com/
äŒæ¥ã³ãŒãRGC
äžå Žæ¥Jul 16, 2021
æé«çµå¶è²¬ä»»è
ãCEOã- -
Regencell Bioscience Holdings Ltdã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
,
,
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
,
,
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Fri, Mar 20
æŽæ°æå»: Fri, Mar 20
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Au (Yat-Gai)
88.56%
Geode Capital Management, L.L.C.
0.08%
ä»ã®
11.36%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Au (Yat-Gai)
88.56%
Geode Capital Management, L.L.C.
0.08%
ä»ã®
11.36%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Individual Investor
88.56%
Investment Advisor/Hedge Fund
0.09%
Investment Advisor
0.01%
ä»ã®
11.34%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Thu, Jan 1
æŽæ°æå»: Thu, Jan 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q4
29
656.42K
0.13%
-38.64K
2025Q3
21
671.84K
0.14%
+311.14K
2025Q2
15
464.50M
93.94%
+23.83M
2025Q1
12
464.34M
93.90%
+23.68M
2024Q4
10
11.60M
89.11%
+20.25K
2024Q3
10
11.58M
89.01%
+24.37K
2024Q2
11
11.57M
88.87%
+5.63K
2024Q1
12
11.56M
88.83%
-17.42K
2023Q4
12
11.57M
88.94%
+13.30K
2023Q3
13
11.56M
88.82%
-12.42K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Au (Yat-Gai)
437.90M
88.56%
--
--
Jul 11, 2025
Geode Capital Management, L.L.C.
419.97K
0.08%
+28.90K
+7.39%
Sep 30, 2025
Vident Asset Management
18.07K
0%
+18.07K
--
Sep 30, 2025
Squarepoint Capital LLP
51.25K
0.01%
-48.59K
-48.67%
Sep 30, 2025
Morgan Stanley Smith Barney LLC
95.00
0%
-500.00
-84.03%
Sep 30, 2025
XTX Markets LLC
38.73K
0.01%
+38.73K
--
Sep 30, 2025
UBS Financial Services, Inc.
337.00
0%
-37.19K
-99.10%
Sep 30, 2025
Morgan Stanley & Co. LLC
37.75K
0.01%
+5.32K
+16.41%
Sep 30, 2025
UBS Switzerland AG
43.00
0%
+43.00
--
Sep 30, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
Fidelity Nasdaq Composite Index ETF
0.02%
SPDR S&P China ETF
0.01%
Fidelity Nasdaq Composite Index ETF
æ¯ç0.02%
SPDR S&P China ETF
æ¯ç0.01%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
Jun 02, 2025
Split
1â38
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
Jun 02, 2025
Split
1â38
